Benzinga
IBM shares fall despite upbeat Q1 results. Wedbush analyst maintains an Outperform rating but cuts PT to $320 due to macro headwinds. Latest Ratings for IBM Date Firm Action From To Jan 2022 BMO Capital Maintains Market Perform Jan 2022 UBS Downgrades Neutral Sell Jan 2022 Goldman Sachs Initiates Coverage On Neutral View More Analyst Ratings for IBM View the Latest Analyst Ratings Importance Rank: 1 read more
Go to News Site